Results 51 to 60 of about 591 (94)

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.

Am J Nephrol, 2017
Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, Bull S, Cannon CP, Charytan DM, de Zeeuw D, Edwards R, Greene T, Heerspink HJL, Levin A, Pollock C, Wheeler DC, Xie J, Zhang H, Zinman B, Desai M, Perkovic V, CREDENCE study investigators.   +21 more
europepmc   +1 more source

Abstracts from the 54^th European Society of Human Genetics (ESHG) Conference: e-Posters. [PDF]

Eur J Hum Genet, 2022
europepmc   +1 more source

Targeted JAM-C deletion in germ cells by Spo11-controlled Cre recombinase.

J Cell Sci, 2011
Pellegrini M, Claps G, Orlova VV, Barrios F, Dolci S, Geremia R, Rossi P, Rossi G, Arnold B, Chavakis T, Feigenbaum L, Sharan SK, Nussenzweig A.   +12 more
europepmc   +1 more source

Profesorado en Letras

, 2022
Foffani, Enrique Abel
core   +1 more source